Showing results (81-90 of 223) with videos related to

Sort By:
Pageof 23
Brain and Behavior|February 28, 2025
Cognitive Outcomes in Myelin Oligodendrocyte Glycoprotein-IgG Associated Disease Compared to Multiple SclerosisEileen Galvani, Jeffrey A Cohen, John T Martin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 6, 2021
Interpreting change on the Symbol Digit Modalities Test in people with relapsing multiple sclerosis using the reliable change methodologyZachary Weinstock, Sarah Morrow, Devon Conway, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 4, 2023
Effect of ibudilast on thalamic magnetization transfer ratio and volume in progressive multiple sclerosisKunio Nakamura, Yufan Zheng, Kedar R Mahajan, et al.
Anesthesiology|January 24, 2008
Severe brachial plexopathy after an ultrasound-guided single-injection nerve block for total shoulder arthroplasty in a patient with multiple sclerosisMatthew D Koff, Jeffrey A Cohen, John J McIntyre, et al.
CNS Drugs|August 9, 2021
Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple SclerosisAmit Bar-Or, Susan M O'Brien, Michael L Sweeney, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2005
Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implicationsRobert J Fox, Elizabeth Fisher, Jean Tkach, et al.
Neurology. Clinical Practice|June 4, 2024
Review of the Longitudinal Management of Autoimmune Encephalitis, Potential Biomarkers, and Novel TherapeuticsAhmad Z Mahadeen, Alise K Carlson, Jeffrey A Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2021
Early age of onset predicts severity of visual impairment in patients with neuromyelitis optica spectrum disorderGabrielle Macaron, Jean Khoury, James Bena, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2017
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosisRobert W Motl, Jeffrey A Cohen, Ralph Benedict, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 2, 2019
Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapiesMarisa P McGinley, Philip A Cola, Robert J Fox, et al.
Pageof 23